Literature DB >> 19565255

Pelvic actinomycosis confirmed after surgery: single center experience.

Min H Choi1, Dae G Hong, Won J Seong, Yoon S Lee, Il S Park.   

Abstract

PURPOSE: To review pelvic actinomycosis confirmed by surgery and summarize clinical aspects.
METHOD: The authors retrospectively reviewed 16 cases that underwent surgical procedures for pelvic actinomycosis between January 1998 and January 2006.
RESULTS: Twelve of the cases (75%) had used intrauterine contraceptive devices for a period of between 8 months and 12 years (mean duration: 5.2 years). Most of the cases presented elevated white blood cell count, neutrophil percentage, CRP value and CA 125 value. Four of the eight cases that were checked by computed tomography presented the possibility of pelvic malignancies. All patients underwent surgery. The mean duration of intravenous antibiotics was 11.8 days and that of peroral antibiotics was 4.3 months. After treatment, there were no complications or recurrences, with the exception of one case of preoperative unilateral ureter obliteration.
CONCLUSION: In diagnosis of pelvic actinomycosis, it is not necessary to consider whether an intrauterine device was being used or not. To distinguish from pelvic malignancy, various methods (including imaging study) should be considered. As for antibiotic treatment, it is believed that shorter and high dose antibiotics therapy will be sufficient treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19565255     DOI: 10.1007/s00404-009-1157-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

1.  Actinomyces in explanted transvaginal mesh: commensal or pathogen?

Authors:  Susana Mustafa Mikhail; Peta Fairweather; Anna Eastman; Gunter Hartel; Zhuoran Chen; Christopher Maher
Journal:  Int Urogynecol J       Date:  2021-01-08       Impact factor: 2.894

2.  Diagnostic dilemma posed by severe pelvic actinomycosis associated with prolonged use of copper intrauterine contraceptive device.

Authors:  Subhayu Bandyopadhyay; Sanjay Sinha; Patrick Fan Wui Chien; Dawn Fleming
Journal:  Clin Pract       Date:  2011-11-25

Review 3.  Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.

Authors:  Florent Valour; Agathe Sénéchal; Céline Dupieux; Judith Karsenty; Sébastien Lustig; Pierre Breton; Arnaud Gleizal; Loïc Boussel; Frédéric Laurent; Evelyne Braun; Christian Chidiac; Florence Ader; Tristan Ferry
Journal:  Infect Drug Resist       Date:  2014-07-05       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.